{
    "2021-08-21": [
        [
            {
                "time": "",
                "original_text": "胰岛素集采将至，甘李、通化东宝龙头能否稳住？诺和诺德、礼来、赛诺菲三大跨国巨头如何破局？谁将是集采“黑马”？国产替代能否实现？",
                "features": {
                    "keywords": [
                        "胰岛素",
                        "集采",
                        "甘李",
                        "通化东宝",
                        "诺和诺德",
                        "礼来",
                        "赛诺菲",
                        "国产替代"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "甘李药业甘精胰岛素在巴拉圭获批",
                "features": {
                    "keywords": [
                        "甘李药业",
                        "甘精胰岛素",
                        "巴拉圭",
                        "获批"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药",
                        "出口"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}